Literature DB >> 1450800

Clinical differentiation of oral ulceration in Behçet's disease.

D M Main1, M A Chamberlain.   

Abstract

Behçet oral ulceration (BOU) is described as being indistinguishable from conventional recurrent oral ulceration (ROU). A clinical comparison between 38 Behçet patients and 38 control ROU cases was effected by completion of a standard questionnaire. Behçet patients reported an increased number of concurrent ulcers and involvement of the soft palate and oropharynx. No differences were detected with respect to duration, frequency, age of onset or family history. In addition, photographs of BOU in 15 patients revealed the concurrence of atypical aphthous and herpetiform varieties. Number, site and appearance of oral ulceration may therefore provide diagnostic features for the development of Behçet's disease.

Entities:  

Mesh:

Year:  1992        PMID: 1450800     DOI: 10.1093/rheumatology/31.11.767

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  13 in total

Review 1.  Behçet's disease: immunopathologic and therapeutic aspects.

Authors:  Robert Meador; George Ehrlich; Joan M Von Feldt
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 2.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 3.  Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome.

Authors:  M T Keogan
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

Review 4.  Pediatric Behçet's disease - clinical aspects and current concepts.

Authors:  Mehmet Yıldız; Oya Köker; Amra Adrovic; Sezgin Şahin; Kenan Barut; Özgür Kasapçopur
Journal:  Eur J Rheumatol       Date:  2019-09-05

5.  The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): a masked and controlled study.

Authors:  A Ince; Y Yazici; V Hamuryudan; H Yazici
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

6.  Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

Authors:  I Kötter; M Zierhut; A K Eckstein; R Vonthein; T Ness; I Günaydin; B Grimbacher; S Blaschke; W Meyer-Riemann; H H Peter; N Stübiger
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

Review 7.  Mucocutaneous lesions of Behcet's disease.

Authors:  Erkan Alpsoy; Christos Constantin Zouboulis; George Edward Ehrlich
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

8.  Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms.

Authors:  Seung-Ho Rhee; Young-Bae Kim; Eun-So Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

9.  Behçet's disease presenting with a hypopharyngeal ulcer.

Authors:  Ozgür Yiğit; Seyhan Alkan; Tülay Başak; Burhan Dadaş
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-02-19       Impact factor: 2.503

10.  Clinical and Pathological Manifestations with Differential Diagnosis in Behçet's Disease.

Authors:  Aysin Kokturk
Journal:  Patholog Res Int       Date:  2011-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.